Home › European CRO Evotec cashes in on strategic partnerships
 

Keywords :   


European CRO Evotec cashes in on strategic partnerships

2014-12-23 08:47:37| Chemicals - Topix.net

Contract drug developer Evotec AG has achieved multiple milestones resulting in a 8m in revenue thanks to its collaborations with Bayer and Janssen Pharmaceuticals. The revenues, which will be recognised in FY 2014, were reached in Evotec's multi-target collaboration with Bayer HealthCare in endometriosis and thanks to its partnership with Janssen for the EVT100 series for the treatment of CNS diseases.

Tags: european partnerships strategic cro

Category:Chemicals

Latest from this category

All news
25.11Dunn-Edwards CEO Karl Altergott to Retire, COO Monte Lewis is Successor
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
Chemicals »
25.11adidas BECKENBAUER
25.11KISS DVD
25.1116
25.113
25.11HiHi Jets DVD CRUSH THE FRONTLINE
25.11SnowMan I DO ME
25.11m.u
25.11ICLS5& 2022
More »